2-羟基-5-(三氟甲氧基)苯甲醛
2-羟基-5-(三氟甲氧基)苯甲醛结构式
|
常用名 | 2-羟基-5-(三氟甲氧基)苯甲醛 | 英文名 | 5-(Trifluoromethoxy)salicylaldehyde |
|---|---|---|---|---|
| CAS号 | 93249-62-8 | 分子量 | 206.119 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | 217.6±35.0 °C at 760 mmHg | |
| 分子式 | C8H5F3O3 | 熔点 | 31-33 °C(lit.) | |
| MSDS | 中文版 美版 | 闪点 | 85.4±25.9 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
|
(E)-2-[(3-Fluoro-phen-yl)imino-meth-yl]-4-(trifluoro-meth-oxy)phenol.
Acta Crystallogr. Sect. E Struct. Rep. Online 66(3) , o510, (2010) The title compound, C(14)H(9)F(4)NO(2), is a Schiff base which adopts the phenol-imine tautomeric form in the solid state. The H atom is located on the hydr-oxy O atom rather than on the N atom. This H atom is involved in a strong intra-molecular O-H⋯N hydrog... |
|
|
2-[(E)-2-Hy-droxy-5-(trifluoro-meth-oxy)benzyl-idene-amino]-4-methyl-phenol.
Acta Crystallogr. Sect. E Struct. Rep. Online 67(1) , o95-o95, (2010) The title compound, C(15)H(12)F(3)NO(3), is a Schiff base which adopts the cis-quinoid form in the solid state. The dihedral angle between the least-squares planes of the benzene rings being 3.6 (1)°. The F atoms of the -CF(3) group are disordered over two se... |
|
|
Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy.
Drug Metab. Dispos. 35(6) , 884-97, (2007) The metabolism, pharmacokinetics, and excretion of a potent and selective substance P receptor antagonist, CP-122,721 [(+)-(2S,3S)-3-(2-methoxy-5-trifluoromethoxybenzylamino)-2-phenylpiperidine], have been studied in six healthy male human subjects [four exte... |
|
|
2-[(E)-(Naphthalen-2-ylimino) methyl]-4-(trifluoromethoxy) phenol. Pekdemir M, et al.
Acta Crystallogr. Sect. E Struct. Rep. Online 68(4) , o10204, (2012)
|